ANRIL upregulates TGFBR1 to promote idiopathic pulmonary fibrosis in TGF-β1-treated lung fibroblasts via sequestering let-7d-5p. This evidence concerns the gene CDKN2B-AS1 and idiopathic pulmonary fibrosis.